Tarrytown-based Regeneron would acquire 23andMe for $256 million under the deal that is pending approval by bankruptcy court and regulators. New York-based biotech giant Regeneron Pharmaceuticals ...

Some claimants may receive thousands of dollars.

Add Yahoo as a preferred source to see more of our stories on Google. Genetic testing company 23andMe, once valued at $6 billion, has filed for bankruptcy. State attorneys general are urging concerned ...

Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based drugmaker is set to take over 23andMe after winning a bankruptcy ...

Pioneering US genetic testing company 23andMe has filed for bankruptcy and is looking for a buyer two years after hackers gained access to millions of profiles. 23andMe, which sells a mail-back saliva ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...

Regeneron Pharmaceuticals, a company that has been analyzing genetic data as part of its drug research for more than a decade, is augmenting its capabilities in a big way with the $256 million ...

23andMe filed for bankruptcy amid financial struggles and fallout after a data breach. Now, potential buyers and investors are weighing the value of its DNA database. One of the world's largest troves ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK (AP) — All of 23andMe’s independent ...